Lazizi Mohamed, Marusza Christopher J, Sexton Shaun A, Middleton Rory G
Trauma and Orthopaedic Surgery, Royal Cornwall Hospitals NHS Trust, Truro, UK.
Bone Jt Open. 2020 Jun 9;1(6):229-235. doi: 10.1302/2633-1462.16.BJO-2020-0045. eCollection 2020 Jun.
Elective surgery has been severely curtailed as a result of the COVID-19 pandemic. There is little evidence to guide surgeons in assessing what processes should be put in place to restart elective surgery safely in a time of endemic COVID-19 in the community.
We used data from a stand-alone hospital admitting and operating on 91 trauma patients. All patients were screened on admission and 100% of patients have been followed-up after discharge to assess outcome.
Overall, 87 (96%) patients remained symptom-free and recovered well following surgery. Four (4%) patients developed symptoms of COVID-19, with polymerase chain reaction ribonucleiuc acid (PCR-RNA) testing confirming infection.
Based on our findings, we propose that if careful cohorting and screening is carried out in a stand-alone cold operating site, it is reasonable to resume elective operating, in a time of endemic but low community prevalence of SAR-Cov2.Cite this article: 2020;1-6:229-235.
由于新型冠状病毒肺炎疫情，择期手术已大幅减少。几乎没有证据可指导外科医生评估在社区中新型冠状病毒肺炎流行期间应采取哪些措施来安全重启择期手术。
我们使用了一家独立医院的数据，该医院收治并为91例创伤患者进行手术。所有患者入院时均接受筛查，100%的患者出院后接受随访以评估预后。
总体而言，87例（96%）患者术后无症状且恢复良好。4例（4%）患者出现新型冠状病毒肺炎症状，聚合酶链反应核糖核酸（PCR-RNA）检测确诊感染。
基于我们的研究结果，我们建议，如果在独立的非热门手术区域进行仔细的队列研究和筛查，在严重急性呼吸综合征冠状病毒2社区流行率较低的情况下，恢复择期手术是合理的。引用本文：2020；1 - 6：229 - 235。
